Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 30.83 USD -3.05% Market Closed
Market Cap: 855.2m USD
Have any thoughts about
Castle Biosciences Inc?
Write Note

Castle Biosciences Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Castle Biosciences Inc
Accrued Liabilities Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Castle Biosciences Inc
NASDAQ:CSTL
Accrued Liabilities
$34.5m
CAGR 3-Years
33%
CAGR 5-Years
50%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Accrued Liabilities
$1.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
5%
Quest Diagnostics Inc
NYSE:DGX
Accrued Liabilities
$176m
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Accrued Liabilities
$21.9B
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
15%
Cigna Corp
NYSE:CI
Accrued Liabilities
$8.9B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Accrued Liabilities
$941.8m
CAGR 3-Years
-16%
CAGR 5-Years
-2%
CAGR 10-Years
10%

See Also

What is Castle Biosciences Inc's Accrued Liabilities?
Accrued Liabilities
34.5m USD

Based on the financial report for Sep 30, 2024, Castle Biosciences Inc's Accrued Liabilities amounts to 34.5m USD.

What is Castle Biosciences Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
50%

Over the last year, the Accrued Liabilities growth was 31%. The average annual Accrued Liabilities growth rates for Castle Biosciences Inc have been 33% over the past three years , 50% over the past five years .

Back to Top